Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
30 hedge funds and large institutions have $8.25M invested in Nemaura Medical, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 6 closing their positions.
59% more capital invested
Capital invested by funds: $5.18M → $8.25M (+$3.07M)
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
1% less call options, than puts
Call options by funds: $737K | Put options by funds: $744K
3% less funds holding
Funds holding: 31 → 30 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$467K |
| 2 |
AIP
ARS Investment Partners
New York
|
+$361K |
| 3 |
State Street
Boston,
Massachusetts
|
+$275K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$205K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$90.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$3.27M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$97.4K |
| 3 |
VF
Virtu Financial
New York
|
-$42K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$33.2K |
| 5 |
Morgan Stanley
New York
|
-$31.2K |
NMRD Hedge Fund Activity: Q1 2021 in Review
30 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q1 2021, worth a combined $8.25M — up 59% from $5.18M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NMRD and 5 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 11 added.
The largest buyer was Geode Capital Management, adding an estimated $467K. The largest seller was Sabby Management, exiting entirely with an estimated $3.27M sold.
- 30 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q1 2021, down from 31 in Q4 2020.
- Funds reported $8.25M of Nemaura Medical, Inc. Common Stock stock for Q1 2021, up 59% quarter-over-quarter.
- 5 funds opened new Nemaura Medical, Inc. Common Stock positions in Q1 2021 and 6 closed out, a net change of -1 holder.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q1 2021 was Geode Capital Management, an estimated $467K added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q1 2021 was Sabby Management, an estimated $3.27M sold.
Based on aggregated 13F filings for Q1 2021.